These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10159647)

  • 41. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A national survey on the effect of pharmaceutical promotion on medical students.
    Vainiomäki M; Helve O; Vuorenkoski L
    Med Teach; 2004 Nov; 26(7):630-4. PubMed ID: 15763854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The devil is in the details: the pharmaceutical industry's use of gifts to physicians as marketing strategy.
    McFadden DW; Calvario E; Graves C
    J Surg Res; 2007 Jun; 140(1):1-5. PubMed ID: 17481979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medical ethics, research and the pharmaceutical industry.
    Abud-Mendoza C
    Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
    [No Abstract]   [Full Text] [Related]  

  • 45. The impact of source credibility characteristics on physicians' satisfaction with pharmaceutical salespeople.
    Lagace RR; Twible JL
    J Ambul Care Mark; 1991; 4(2):53-63. PubMed ID: 10110441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
    Katz D; Caplan AL; Merz JF
    Am J Bioeth; 2003; 3(3):39-46. PubMed ID: 14594489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of legislative changes in drug promotion on medical students: questionnaire survey.
    Vuorenkoski L; Valta M; Helve O
    Med Educ; 2008 Dec; 42(12):1172-7. PubMed ID: 19120947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cheap trinkets, effective marketing: small gifts from drug companies to physicians.
    Brett AS
    Am J Bioeth; 2003; 3(3):52-4. PubMed ID: 14594493
    [No Abstract]   [Full Text] [Related]  

  • 49. Are sales representatives and the sale strategies of pharmaceutical companies getting too aggressive towards physicians?
    Bernardi D; Errante D; Bianco A; Salvagno L
    Ann Oncol; 2007 Mar; 18(3):607. PubMed ID: 17164230
    [No Abstract]   [Full Text] [Related]  

  • 50. Attitudes of internal medicine faculty and residents toward professional interaction with pharmaceutical sales representatives.
    McKinney WP; Schiedermayer DL; Lurie N; Simpson DE; Goodman JL; Rich EC
    JAMA; 1990 Oct; 264(13):1693-7. PubMed ID: 2398609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Questionnaire survey on sponsorship of Continuing Medical Education program by pharmaceutical companies.
    Jain MM; Khatib SA; Shenoi A
    Indian Pediatr; 2000 Feb; 37(2):190-2. PubMed ID: 10745416
    [No Abstract]   [Full Text] [Related]  

  • 52. Characteristics of physicians who frequently see pharmaceutical sales representatives.
    Alkhateeb FM; Khanfar NM; Clauson KA
    J Hosp Mark Public Relations; 2009; 19(1):2-14. PubMed ID: 19197653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.
    Makowska M
    PLoS One; 2017; 12(9):e0184862. PubMed ID: 28926592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review.
    Lotfi T; Morsi RZ; Rajabbik MH; Alkhaled L; Kahale L; Nass H; Brax H; Fadlallah R; Akl EA
    BMC Health Serv Res; 2016 Feb; 16():57. PubMed ID: 26883210
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Practical application of the charter of pharmaceutical sales visit].
    Leroy B; Uhart M; Lajoinie A; Maire P; Ducher M; Bourguignon L
    Ann Pharm Fr; 2012 Nov; 70(6):348-52. PubMed ID: 23177561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions between doctors and pharmaceutical sales representatives in a former communist country. The ethical issues.
    Makowska M
    Camb Q Healthc Ethics; 2014 Jul; 23(3):349-55. PubMed ID: 24865182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The assessment of pharmaceutical sales representatives by family physicians--does it affect the prescribing index?
    Klemenc-Ketis Z; Kersnik J
    Fam Pract; 2013 Jun; 30(3):320-4. PubMed ID: 23241163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do ethical Guidelines make a difference to decision-making?
    Osborn M; Day R; Komesaroff P; Mant A
    Intern Med J; 2009 Dec; 39(12):800-5. PubMed ID: 19323704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. National survey of hospital policies on pharmaceutical sales representatives' activities.
    Thomas J
    Am J Hosp Pharm; 1987 Jun; 44(6):1334-40. PubMed ID: 3618609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical student views on interactions with pharmaceutical representatives.
    Ganzini L; Chen Z; Peters D; Misra S; Macht M; Osborne M; Keepers G
    Acad Psychiatry; 2012 May; 36(3):183-7. PubMed ID: 22751818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.